Recognizing the People Who Taught Us to Never Settle: Arnaud

Meet the first Sanofian torchbearer for the Olympic Torch Relay Paris 2024.

Our Latest News

Social Impact

June 20, 2024

Childhood Cancer R&D Program: Developing and Accelerating Novel Therapies for Children With Cancer

United by Purpose

Each of us plays a unique role in bringing our purpose to life.

Sanofi X Paris 2024

We’re proud to be premium partner of Paris 2024.

Science and sport aren’t that different. Just like athletes do, we overcome setbacks to keep moving forward, not just for ourselves, but for our patients, colleagues, families and friends.

About Us

Who We Are

We are an innovative global healthcare company.

Our Pipeline


Therapeutic areas


Compounds in clinical development


Clinical trials in phase 3

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Our Latest Press Releases

June 21, 2024
Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee
June 21, 2024
Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran
June 20, 2024
Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa
June 3, 2024
Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3